2D monolayer gastric organoids (2DMGOs)-on-a-chip have consistent structures and can live for more than a year in culture. This state-of-the-art cell physiological system in a microfluidic device provides a way to investigate biomedically relevant, stimuli-dependent cellular responses in a variety of differentiated 2DMGOs.
Keywords: Helicobacter pylori; drug screening; gastric cancer; microfluidic device; personalized medicine.
Copyright © 2020 Elsevier Ltd. All rights reserved.